(Q34547192)

2 August 2017

1 reference

title

Clinical cancer vaccine trials (English)

1 reference

2 August 2017

1 reference

3

Alexander Knuth

1 reference

2 August 2017

1

Elke Jäger

1 reference

2 August 2017

Dirk Jäger

2

1 reference

2 August 2017

publication date

1 April 2002

1 reference

Current Opinion in Immunology

2 August 2017

published in

1 reference

2 August 2017

volume

14

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

178-182

1 reference

Progress in human tumour immunology and immunotherapy

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Oncogenic proteins as tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Human papillomavirus vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

HLA-peptide tetrameric complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900318-7

7 January 2021

10.1016/S0952-7915(02)00318-7

Identifiers

DOI

1 reference

2 August 2017

1 reference